Knowledge Hub
A structured library of practical guidance across GMP compliance, investigations, documentation, audits, supplier quality, and risk-based decision-making.
VerethiQ organizes pharmaceutical quality systems into six connected domains to support clearer execution, stronger compliance, and better operational decisions across regulated environments.
HACCP & Hazard Analysis
HACCP helps GMP organizations identify and control hazards before they impact product quality or patient safety. This guide explains CCPs, monitoring, corrective actions, and reassessment.
FMEA Step-by-Step
FMEA helps GMP organizations identify and prioritize potential failures before they occur. This guide explains step-by-step execution, scoring logic, mitigation, and inspection expectations.
Risk vs Uncertainty in GMP
Understanding the difference between risk and uncertainty is critical for effective QRM. This article explains how confusion between the two leads to weak decisions and inspection risk.
Risk Demonstration in GMP
Regulators do not assess risk through templates - they assess decisions. This article explains how risk is evaluated during inspection and what signals effective QRM.
QRM Terminology Explained
QRM terminology shapes how risk-based decisions are made. This article explains how key terms are interpreted in practice and why inconsistency leads to weak decisions.
Risk Management Process Steps
Understand the step-by-step risk management process in GMP systems and how regulators expect it to be applied in practice.
ICH Q9 Explained
ICH Q9 defines how risk-based decisions should be made in GMP systems. This guide explains its principles, process, and what regulators actually expect in practice.
Staying Current with GMP Changes
GMP regulations change slowly, but inspection emphasis evolves continuously. This article explains how to build a structured regulatory monitoring and review process that keeps quality systems aligned without unnecessary disruption.
WHO GMP: Structure & Focus
WHO GMP provides a global reference framework for pharmaceutical quality. This article explains its structure, regulatory role, and how it aligns with FDA and EU GMP expectations for international manufacturers.
EU GMP Annex 1: Key Updates
EU GMP Annex 1 introduces strengthened expectations for contamination control strategy, environmental monitoring, and sterile manufacturing oversight. This article explains the key updates and what they mean for inspection readiness.
US FDA vs EU GMP vs PIC/S
Global manufacturers must navigate FDA, EU GMP, and PIC/S frameworks. This article explains their structural differences, inspection styles, and how harmonized principles shape compliance expectations across regions.
Post-Implementation Verification
Post-implementation verification confirms that approved changes achieved intended outcomes without unintended risk. Learn how to structure monitoring and meet inspection expectations.